KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Capital Expenditures (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -6.22%
Dec 31, 2025 15.63%
Sep 30, 2025 -11.36%
Jun 30, 2025 38.85%
Mar 31, 2025 -31.22%
Dec 31, 2024 16.67%
Sep 30, 2024 23.66%
Jun 30, 2024 -7.75%
Mar 31, 2024 -13.94%
Dec 31, 2023 -3.51%
Sep 30, 2023 32.05%
Jun 30, 2023 -6.83%
Mar 31, 2023 -19.65%
Dec 31, 2022 40.08%
Sep 30, 2022 -9.19%
Jun 30, 2022 7.51%
Mar 31, 2022 -20.94%
Dec 31, 2021 18.52%
Sep 30, 2021 28.57%
Jun 30, 2021 21.39%
Mar 31, 2021 -38.87%
Dec 31, 2020 84.97%
Sep 30, 2020 16.79%
Jun 30, 2020 -29.57%
Mar 31, 2020 -25.90%
Dec 31, 2019 32.11%
Sep 30, 2019 -0.52%
Jun 30, 2019 -6.37%
Mar 31, 2019 -29.66%
Dec 31, 2018 29.46%
Sep 30, 2018 13.13%
Jun 30, 2018 -17.15%
Mar 31, 2018 -5.91%
Dec 31, 2017 -3.05%
Sep 30, 2017 5.65%
Jun 30, 2017 -14.78%
Mar 31, 2017 -21.56%
Dec 31, 2016 8.80%
Sep 30, 2016 30.65%
Jun 30, 2016 7.85%
Mar 31, 2016 -15.09%
Dec 31, 2015 21.79%
Sep 30, 2015 41.82%
Jun 30, 2015 21.32%
Mar 31, 2015 -28.80%
Dec 31, 2014 78.50%
Sep 30, 2014 -2.73%
Jun 30, 2014 -6.78%
Mar 31, 2014 -41.00%
Dec 31, 2013 61.29%
Sep 30, 2013 26.53%
Jun 30, 2013 -14.78%
Mar 31, 2013 -34.29%
Dec 31, 2012 27.74%
Sep 30, 2012 21.24%
Jun 30, 2012 -8.13%
Mar 31, 2012 -8.21%
Dec 31, 2011 59.52%
Sep 30, 2011 13.51%
Jun 30, 2011 -1.33%
Mar 31, 2011 -40.00%
Dec 31, 2010 40.45%
Sep 30, 2010 9.88%
Jun 30, 2010 -37.21%
Mar 31, 2010 -34.18%
Dec 31, 2009 15.98%